July 9 (Reuters) - Ipsen SA:
* IPSEN ANNOUNCES UPDATED INDICATION FOR DYSPORT® (ABOBOTULINUMTOXINA) FOR THE TREATMENT OF SPASTICITY IN CHILDREN Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)
Our Standards: The Thomson Reuters Trust Principles.